Compound: Retatrutide Format: Lyophilized peptide research vial Available Strengths: 10MG, 20MG, and 30MG Research Category: GLP-1 / GIP / glucagon triple agonist peptide research Research Focus: Incretin biology, metabolic regulation, GLP-1 receptor pathway research, GIP receptor signaling, glucagon receptor models, substrate utilization, energy-balance biology, and appetite-associated pathway research
The two most common concentrations are 2.5 mg/mL and 5 mg/mL
This dose exceeds 1 mL (100 units) at this concentration and cant be drawn in a single standard insulin syringe
doi: 10.1002/14651858.CD004655.pub3
The two compounds are paired in this blend because their mechanisms are mechanistically complementary BPC-157 modulates nitric oxide signaling and growth factor expression to support gastrointestinal, vascular, and connective-tissue healing, while TB-500 sequesters G-actin to drive cell migration, angiogenesis, and post-injury tissue remodeling
Contact us with any questions or to schedule your appointment and our team will reach out to you quickly
